Skip to content
OpenCapital
Get started

Integra LifeSciences IART Q1 2026 earnings

Reported May 5, 2026 · Before market open

Revenue$391.9MBeat by $10.1M
EPS$0.54Beat by $0.13
Revenue estimate$381.8M
EPS estimate$0.41

Next report

Jul 29, 2026 (Today)
Revenue estimate$417.5M
EPS estimate$0.48
View report

Financials

Q1 2026

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation & ratios

Valuation

as of 07/28/26
See full
Market cap$1.52B+49.2%
Enterprise value$3.27B+20.9%
P/S0.9×+0.3×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%—

Returns & leverage

See full
Return on equity-38.6%—
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Segments

By product

See full
Neurosurgery$198.2M+3.8%
Wound Reconstruction$79.6M+6.5%
Instruments$47.2M-7.3%
ENT$37.7M-2.8%
Private Label$29.1M+7.1%

By geography

See full
Asia Pacific$45.2M+0.2%
Europe$40.0M+13.1%
Rest of World$17.4M-13.2%

By segment

See full
Specialty Surgery$283.1M—
Tissue Reconstruction$108.8M—

Versus estimates

Revenue

Q1 2026$391.9MBeat by $10.1M
Q4 2025$434.9MBeat by $5.3MQ3 2025$402.1MMiss by $27.6MQ2 2025$415.6MBeat by $1.3MQ1 2025$382.7MMiss by $19.9MQ4 2024$442.6MBeat by $30.9M

Diluted EPS

Q1 2026$0.54Beat by $0.13
Q4 2025$0.83Beat by $0.04Q3 2025$0.54Beat by $0.11Q2 2025$0.45Beat by $0.02Q1 2025$0.41Miss by $0.02Q4 2024$0.97Beat by $0.11

Ask the moment Integra LifeSciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Integra LifeSciences report Q1 2026 earnings?
Integra LifeSciences (IART) reported Q1 2026 earnings on May 5, 2026 before market open.
What were Integra LifeSciences's Q1 2026 revenue and EPS?
Integra LifeSciences reported revenue of $391.9M and eps of $0.54 for Q1 2026.
Did Integra LifeSciences beat estimates in Q1 2026?
Revenue beat the consensus estimate of $381.8M by $10.1M. EPS beat the consensus estimate of $0.41 by $0.13.
How did Integra LifeSciences's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 2.4% from $382.7M a year earlier and eps grew 31.7% from $0.41.
Where can I find Integra LifeSciences's Q1 2026 SEC filings?
You can read the 8-K earnings release (0000917520-26-000033) and the 10-Q periodic report (0000917520-26-000041) directly on SEC EDGAR. The filing index links above go to sec.gov.